BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24614628)

  • 21. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents.
    Moore P; Barlis P; Spiro J; Ghimire G; Roughton M; Di Mario C; Wallis W; Ilsley C; Mitchell A; Mason M; Kharbanda R; Vincent P; Sherwin S; Dalby M
    JACC Cardiovasc Interv; 2009 May; 2(5):437-44. PubMed ID: 19463468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between post-stent strut apposition and follow-up strut coverage assessed by a contour plot optical coherence tomography analysis.
    Kim JS; Ha J; Kim BK; Shin DH; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Interv; 2014 Jun; 7(6):641-51. PubMed ID: 24835329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of underlying plaque type on strut coverage in the early phase after drug-eluting stent implantation.
    Kakizaki R; Minami Y; Hashikata T; Nemoto T; Hashimoto T; Fujiyoshi K; Meguro K; Shimohama T; Tojo T; Ako J
    Coron Artery Dis; 2018 Dec; 29(8):624-631. PubMed ID: 29975201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
    Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between stent malapposition and incomplete neointimal coverage after drug-eluting stent implantation.
    Kim BK; Hong MK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y
    J Interv Cardiol; 2012 Jun; 25(3):270-7. PubMed ID: 22372890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of statin treatment on strut coverage after drug-eluting stent implantation.
    Suh Y; Kim BK; Shin DH; Kim JS; Ko YG; Choi D; Jang Y; Hong MK
    Yonsei Med J; 2015 Jan; 56(1):45-52. PubMed ID: 25510746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optical coherence tomographic evaluation of the effect of cigarette smoking on vascular healing after sirolimus-eluting stent implantation.
    Gao L; Park SJ; Jang Y; Lee S; Tian J; Minami Y; Jia H; Ong D; Soeda T; Vergallo R; Lee H; Yu B; Uemura S; Jang IK
    Am J Cardiol; 2015 Mar; 115(6):751-7. PubMed ID: 25620038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Visualization of intimal proliferation of drug-eluting stent and bare mental stent by use of optical coherence tomography].
    Chen BX; Ma FY; Luo W; Xie WL; Sun SH; Guo XM; Wang F; Zhao XZ; Chu XW
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(16):1102-6. PubMed ID: 16796834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential healing response attributed to culprit lesions of patients with acute coronary syndromes and stable coronary artery after implantation of drug-eluting stents: an optical coherence tomography study.
    Räber L; Zanchin T; Baumgartner S; Taniwaki M; Kalesan B; Moschovitis A; Garcia-Garcia HM; Justiz J; Pilgrim T; Wenaweser P; Meier B; Jüni P; Windecker S
    Int J Cardiol; 2014 May; 173(2):259-67. PubMed ID: 24631113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serial optical coherence tomography-based observation of strut coverage on drug-eluting stent crossing side-branch vessels.
    Lee SY; Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    J Invasive Cardiol; 2012 Nov; 24(11):569-73. PubMed ID: 23117310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial.
    McKenney JM; Jones PH; Adamczyk MA; Cain VA; Bryzinski BS; Blasetto JW;
    Curr Med Res Opin; 2003; 19(8):689-98. PubMed ID: 14687438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized comparison between 3-month Cre8 DES vs. 1-month Vision/Multilink8 BMS neointimal coverage assessed by OCT evaluation: the DEMONSTRATE study.
    Prati F; Romagnoli E; Valgimigli M; Burzotta F; De Benedictis M; Ramondo A; Mehran R; Stella PR
    Int J Cardiol; 2014 Oct; 176(3):904-9. PubMed ID: 25171966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ComparisOn of neointimal coVerage betwEen zotaRolimus-eluting stent and everolimus-eluting stent using Optical Coherence Tomography (COVER OCT).
    Kim JS; Kim BK; Jang IK; Shin DH; Ko YG; Choi D; Hong MK; Cho YK; Nam CW; Hur SH; Choi JH; Song YB; Hahn JY; Choi SH; Gwon HC; Jang Y
    Am Heart J; 2012 Apr; 163(4):601-7. PubMed ID: 22520526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation neointimal coverage in patients with coronary artery aneurysm formation after drug-eluting stent implantation by optical coherence tomography.
    Feng T; Yundai C; Hongbin L; Lian C; Zhijun S; Jun G; Qinhua J; Tao Z
    Int J Cardiovasc Imaging; 2013 Dec; 29(8):1677-83. PubMed ID: 24030292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized comparison of stent strut coverage following angiography- or optical coherence tomography-guided percutaneous coronary intervention.
    Kim JS; Shin DH; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Rev Esp Cardiol (Engl Ed); 2015 Mar; 68(3):190-7. PubMed ID: 25487222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study.
    Davlouros PA; Nikokiris G; Karantalis V; Mavronasiou E; Xanthopoulou I; Damelou A; Tsigkas G; Alexopoulos D
    Int J Cardiol; 2011 Sep; 151(2):155-9. PubMed ID: 20605242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two different sampling intervals for optical coherence tomography evaluation of neointimal healing response after coronary stent implantation.
    Varho V; Nammas W; Kiviniemi TO; Sia J; Romppanen H; Pietilä M; Airaksinen JK; Karjalainen PP
    Int J Cardiol; 2017 Jan; 227():194-200. PubMed ID: 27839810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed coverage of drug-eluting stents after interventional revascularisation of chronic total occlusions assessed by optical coherence tomography: the ALSTER-OCT-CTO registry.
    Heeger CH; Busjahn A; Hildebrand L; Fenski M; Lesche F; Meincke F; Kuck KH; Bergmann MW
    EuroIntervention; 2016 Jan; 11(9):1004-12. PubMed ID: 25287264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.